Breakthrough in tracking a cause of chronic infections

Feb 24, 2010
Breakthrough in tracking a cause of chronic infections
Three-dimensional enlarged image of E. coli bacterium. Photo courtesy of Istock/Sebastian Kaulitzki.

(PhysOrg.com) -- Northeastern University researchers have identified a protein that enables bacterial cells to survive antibiotic treatment.

This discovery by biology professor Kim Lewis and his team, published in the February 22 issue of the journal , reveals for the first time the mechanism by which bacteria maintain a chronic infection in spite of aggressive therapy with antibiotics.

Lewis and his team previously discovered that pathogens responsible for form small populations of dormant , called persisters, which are not killed by antibiotics. Antibiotics function only on active cells, so when treatment ceases, persisters grow and repopulate, causing a relapse. The protein identified by the Northeastern researchers, known as TisB, triggers a cellular response that leads to the development of persister cells.

“The paradox of chronic infections is that, in many cases, pathogens aren’t resistant to antibiotics, yet the don’t work,” said Lewis, director of Northeastern’s Antimicrobial Discovery Center. “We now better understand what happens inside the cell that enables pathogens to become inactive and cause relapsing infections.”

The research was conducted using E. coli, a common found in food and water supplies, and a frequently prescribed antibiotic, ciprofloxacin. Lewis and his team discovered that while the antibiotic was killing most bacteria, it also induced production of TisB in some , which resulted in the formation of persisters.

These findings represent the first time scientists have been able to identify — at the molecular level — how persister cells are formed, said Lewis.

“This is the first step towards understanding the complex workings of how cells evolve to protect themselves,” said Lewis. “The more we know, the better equipped we will be to develop counter measures and effective treatments against bacterial infections.”

Explore further: YEATS protein potential therapeutic target for cancer

add to favorites email to friend print save as pdf

Related Stories

Nanotechnology used to probe effectiveness of antibiotics

Feb 04, 2009

A group of researchers led by scientists from the London Centre for Nanotechnology, in collaboration with a University of Queensland researcher, have discovered a way of using tiny nano-probes to help understand how an antibiotic ...

Scientists discover how some bacteria survive antibiotics

Apr 30, 2008

Researchers at the University of Illinois at Chicago have discovered how some bacteria can survive antibiotic treatment by turning on resistance mechanisms when exposed to the drugs. The findings, published in the April 24 ...

Researchers discover new ways to treat chronic infections

Dec 18, 2009

Researchers at Binghamton University, State University of New York, have identified three key regulators required for the formation and development of biofilms. The discovery could lead to new ways of treating ...

Recommended for you

YEATS protein potential therapeutic target for cancer

3 hours ago

Federal Express and UPS are no match for the human body when it comes to distribution. There exists in cancer biology an impressive packaging and delivery system that influences whether your body will develop cancer or not.

Precise and programmable biological circuits

4 hours ago

A team led by ETH professor Yaakov Benenson has developed several new components for biological circuits. These components are key building blocks for constructing precisely functioning and programmable bio-computers.

User comments : 0